$7.13 Billion in Sales Expected for Molina Healthcare, Inc. (NYSE:MOH) This Quarter

Equities research analysts expect Molina Healthcare, Inc. (NYSE:MOH) to post sales of $7.13 billion for the current quarter, Zacks reports. Five analysts have made estimates for Molina Healthcare’s earnings, with the highest sales estimate coming in at $7.43 billion and the lowest estimate coming in at $6.78 billion. Molina Healthcare posted sales of $5.24 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 36.1%. The firm is scheduled to issue its next quarterly earnings report on Wednesday, February 9th.

According to Zacks, analysts expect that Molina Healthcare will report full-year sales of $27.52 billion for the current financial year, with estimates ranging from $27.14 billion to $27.79 billion. For the next fiscal year, analysts forecast that the company will report sales of $30.81 billion, with estimates ranging from $29.93 billion to $31.79 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that follow Molina Healthcare.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, October 27th. The company reported $2.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.80 by $0.03. The firm had revenue of $7.04 billion for the quarter, compared to analyst estimates of $6.82 billion. Molina Healthcare had a return on equity of 25.93% and a net margin of 2.31%. Molina Healthcare’s revenue was up 40.2% compared to the same quarter last year. During the same period in the previous year, the company earned $3.36 earnings per share.

MOH has been the topic of a number of analyst reports. Credit Suisse Group lifted their price target on Molina Healthcare from $318.00 to $330.00 and gave the stock an “outperform” rating in a research note on Friday, October 29th. Wells Fargo & Company lifted their price target on Molina Healthcare from $256.00 to $281.00 and gave the company an “underweight” rating in a report on Tuesday, November 2nd. Morgan Stanley lifted their price target on Molina Healthcare from $316.00 to $397.00 and gave the company an “overweight” rating in a report on Friday, October 29th. Truist Securities lifted their price target on Molina Healthcare from $300.00 to $330.00 and gave the company a “buy” rating in a report on Monday, September 20th. Finally, BMO Capital Markets lifted their price target on Molina Healthcare from $300.00 to $315.00 and gave the company an “outperform” rating in a report on Friday, July 30th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Buy” and an average target price of $310.02.

In other news, Director Daniel Cooperman sold 5,000 shares of Molina Healthcare stock in a transaction on Monday, November 15th. The stock was sold at an average price of $309.13, for a total value of $1,545,650.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Ronna Romney sold 300 shares of the business’s stock in a transaction on Monday, November 8th. The stock was sold at an average price of $305.01, for a total value of $91,503.00. The disclosure for this sale can be found here. 1.49% of the stock is owned by insiders.

Several hedge funds have recently added to or reduced their stakes in the company. Dark Forest Capital Management LP purchased a new stake in shares of Molina Healthcare during the third quarter worth $39,000. Cullen Frost Bankers Inc. purchased a new stake in Molina Healthcare in the second quarter worth about $41,000. Eubel Brady & Suttman Asset Management Inc. purchased a new position in shares of Molina Healthcare during the second quarter valued at approximately $47,000. First Horizon Advisors Inc. lifted its holdings in shares of Molina Healthcare by 35.8% during the third quarter. First Horizon Advisors Inc. now owns 326 shares of the company’s stock valued at $50,000 after purchasing an additional 86 shares during the last quarter. Finally, Berman Capital Advisors LLC raised its holdings in Molina Healthcare by 125.5% in the 2nd quarter. Berman Capital Advisors LLC now owns 212 shares of the company’s stock worth $53,000 after acquiring an additional 118 shares during the last quarter. 93.73% of the stock is owned by institutional investors.

MOH traded up $0.50 during trading on Friday, reaching $307.00. The company had a trading volume of 135,666 shares, compared to its average volume of 297,481. The firm’s 50-day simple moving average is $290.26 and its 200 day simple moving average is $269.12. The company has a market cap of $17.93 billion, a price-to-earnings ratio of 30.49, a PEG ratio of 1.06 and a beta of 0.69. Molina Healthcare has a 12-month low of $196.08 and a 12-month high of $316.04. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.54 and a current ratio of 1.54.

About Molina Healthcare

Molina Healthcare, Inc engages in the provision of health care services. It operates through the Health Plans and Other segments. The Health Plans segment consists of health plans in 11 states and the Commonwealth of Puerto Rico and includes direct delivery business. The Other segment includes the historical results of the MMIS and behavioral health subsidiaries.

Recommended Story: Stock Market News Sentiment

Get a free copy of the Zacks research report on Molina Healthcare (MOH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.